Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Default robots file version:2 User-agent: * Disallow: /calendar/action* Disallow: /events/action* Allow: /*.css Allow: /*.js Disallow: /*? Crawl-delay: 3 |
Title | January Therapeutics – Precision Oncology: Smart Targeting Technology for Small Molecule |
Description | Targeted Skip to content Home About Leadership Scientific Advisors Business Advisors News & Events Contact Menu Home About Leadership Scientific Advisors Business |
Keywords | N/A |
WebSite | januarytx.com |
Host IP | 198.71.232.3 |
Location | United States |
Site | Rank |
US$2,962,904
Last updated: 2022-07-08 10:15:00
januarytx.com has Semrush global rank of 3,572,274. januarytx.com has an estimated worth of US$ 2,962,904, based on its estimated Ads revenue. januarytx.com receives approximately 341,874 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, januarytx.com is safe to visit. |
Purchase/Sale Value | US$2,962,904 |
Daily Ads Revenue | US$2,735 |
Monthly Ads Revenue | US$82,050 |
Yearly Ads Revenue | US$984,596 |
Daily Unique Visitors | 22,792 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
januarytx.com. | A | 599 | IP: 198.71.232.3 |
januarytx.com. | NS | 3600 | NS Record: ns58.domaincontrol.com. |
januarytx.com. | NS | 3600 | NS Record: ns57.domaincontrol.com. |
januarytx.com. | MX | 600 | MX Record: 0 januarytx-com.mail.protection.outlook.com. |
januarytx.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
januarytx.com. | TXT | 600 | TXT Record: NETORGFT2368461.onmicrosoft.com |
Skip to content Home About Leadership Scientific Advisors Business Advisors News & Events Contact Menu Home About Leadership Scientific Advisors Business Advisors News & Events Contact Targeted Oncology: Biologically Validated. Chemistry Enabled. Albumin Protected. Contact Us Exploiting metabolic pathways to target tumors with effective therapeutics. Our initial development programs are focused on oncology, specifically related to therapeutics. Lorem ipsum Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum Lorem ipsum dolor sit amet, consectetur adipiscing elit Lorem ipsum Lorem ipsum dolor sit amet, consectetur adipiscing elit About Us Our Product Strategy January Therapeutics is targeting cell-essential drivers of cancer which cannot be successfully drugged by chemistry alone. January’s technology exploits the dysregulated metabolic pathways in cancer and uses albumin to preferentially deliver drug to tumors while sparing healthy cells. Thomas B. Broudy, PhD CEO |
HTTP/1.1 301 Moved Permanently location: https://januarytx.com/ Vary: Accept-Encoding Server: DPS/1.12.0 X-SiteId: 2000 Set-Cookie: dps_site_id=2000; path=/ Date: Sat, 30 Oct 2021 06:42:49 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.12.0 x-siteid: 2000 set-cookie: dps_site_id=2000; path=/; secure date: Sat, 30 Oct 2021 06:42:49 GMT |
Domain Name: JANUARYTX.COM Registry Domain ID: 2065911719_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-10-17T00:18:11Z Creation Date: 2016-10-13T15:30:35Z Registry Expiry Date: 2023-10-13T15:30:35Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS57.DOMAINCONTROL.COM Name Server: NS58.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T17:29:33Z <<< |